Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices

Robert Przybylski1, Molly Craig2, Matthew Lippmann2

  • 1Department of Cardiology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. robert.przybylski@childrens.harvard.edu.

Pediatric Cardiology
|December 1, 2021
PubMed

Insights

Physical activity significantly decreased in children with cardiac rhythm management devices during the COVID-19 pandemic. Activity levels recovered by June, highlighting the need for strategies to maintain exercise during health crises.

Area of Science:

  • Pediatrics
  • Cardiology
  • Public Health

Background:

  • Decreased physical activity is linked to cardiovascular, metabolic, and mental health issues.
  • Limited data exists on physical activity changes in children with cardiovascular disease during the COVID-19 pandemic.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic onset on physical activity levels in children with cardiac rhythm management devices.
  • To hypothesize a decrease in physical activity at the pandemic's start.

Main Methods:

  • A single-center, retrospective cohort study was performed.
  • 144 children (aged <19 years) with cardiac rhythm management devices and >80% device-measured physical activity data from Feb-June 2020 were included.
  • Patients with significant neurologic/neuromuscular disease were excluded.

Main Results:

  • A significant decrease in device-measured physical activity was observed from baseline (Feb 3-March 9).
  • Physical activity declined by up to 21% from mid-March through early May.
  • Activity levels returned to pre-pandemic levels by June.

Conclusions:

  • Physical activity sharply declined in children with cardiac rhythm management devices at the COVID-19 pandemic's onset.
  • These findings underscore the importance of strategies to maintain physical activity during pandemics and future public health crises.

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
984
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.5K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
87
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
152